Compare Abbott Laboratories (ABT) vs Western Union Co (WU) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Western Union Co — how do they compare? Abbott Laboratories trades at $94.9 (market cap $166.94B), while Western Union Co trades at $7.73 (market cap $2.48B). The key difference: Abbott Laboratories is far larger — about 67.3× Western Union Co's market cap, and Western Union Co pays the higher dividend (11.82%). Which is the better fit depends on your goals.
| ABT | WU | |
|---|---|---|
Market Cap | $166.94B | $2.48B |
Sector | Health | Technology |
52-Week High | $136.62 | $10.28 |
52-Week Low | $82.57 | $7.04 |
Enterprise Value | $193.69B | $2.18B |
Dividend Yield | 2.63% | 11.82% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
Western Union (WU) trades at $7.95, down 0.75% on the day, with mixed technical signals but a bullish overall trend. The stock shows strong profitability with a 10.88% net margin and 47.66% ROE, and valuation metrics like a P/E of 5.87 and P/S of 0.63 appear attractive. Recent developments include a partnership with Total Wireless for fee-free money transfers and progress on the Intermex acquisition, signaling digital expansion. However, Q1 2026 earnings missed expectations, and the company faces a high debt load with a debt-to-asset ratio of 34.64% as of 2025.
The outlook for WU is cautiously optimistic, with potential upside from digital growth initiatives and a high dividend yield, but risks include competitive pressures, recent earnings volatility, and significant leverage. Analyst sentiment is mixed, with a majority Hold rating, reflecting balanced views on growth prospects versus financial constraints.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Western Union Co
Western Union provides domestic and international money transfers through its global network of about 500,000 outside agents. It is the largest money transfer company in the world and one of only a few companies with a truly global agent network.
Read more on WU →
